Form 4: Schrodinger Director Rosana Kapeller-Libermann Receives Equity Awards

Schrodinger, Inc. Director Rosana Kapeller-Libermann was granted 5,997 restricted stock units and options to purchase 9,341 shares of common stock on June 18, 2025, as part of the company's 2022 Equity Incentive Plan.

Summary

• Rosana Kapeller-Libermann, a Director of Schrodinger, Inc. (SDGR), was granted equity awards on June 18, 2025.
• She received 5,997 Restricted Stock Units (RSUs) under the Issuer's 2022 Equity Incentive Plan, with each RSU representing a contingent right to receive one share of common stock.
• These RSUs are scheduled to vest on the twelve-month anniversary of the grant date (June 18, 2026) or, if earlier, the date of the next annual meeting of stockholders, contingent upon her continued service.
• The settlement of these RSUs will be deferred until the earlier of 30 days following her separation from service or certain change in control events.
• Additionally, she was granted options to purchase 9,341 shares of common stock, also on June 18, 2025, with an exercise price of $21.05 per share.
• These stock options will vest on the twelve-month anniversary of the grant date (June 18, 2026) or the next annual meeting of stockholders, subject to continued service, and are set to expire on June 18, 2035.
• Following these transactions, Ms. Kapeller-Libermann beneficially owns a total of 17,247 shares of common stock (including the 5,997 unvested RSUs) and 9,341 stock options.

Sentiment

Score: 7

Explanation: The filing indicates a standard equity grant to a director, which is a positive for aligning interests and retention. There are no negative implications or unusual aspects reported.

Positives

• The grant of equity awards to a director aligns their financial interests with those of shareholders, promoting long-term commitment and performance.
• The awards are part of the company's established 2022 Equity Incentive Plan, indicating a structured and transparent approach to executive and director compensation and retention.

Future Outlook

The vesting schedules for the granted RSUs and stock options indicate a future commitment period for the director, with vesting contingent on continued service for at least twelve months or until the next annual meeting of stockholders. The deferred settlement of RSUs until separation from service or a change in control event suggests a long-term retention strategy.

Industry Context

This Form 4 filing reflects a routine equity compensation event for a director at a publicly traded biotechnology or software company (Schrodinger, Inc. operates in drug discovery software). Such grants are common practice across industries to align executive and director incentives with shareholder value creation and to retain key talent. The specific terms, such as vesting over one year, are standard for such awards.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with those of shareholders, potentially leading to better long-term performance.
• Employees: The use of an equity incentive plan for directors may signal a broader commitment to performance-based compensation across the company.

Next Steps

• Continued service by Rosana Kapeller-Libermann to facilitate vesting of RSUs and stock options.
• Vesting of RSUs and stock options on June 18, 2026, or the date of the next annual meeting of stockholders, whichever is earlier.
• Potential settlement of RSUs upon separation from service or a change in control event.
• Potential exercise of stock options by June 18, 2035.

Key Dates

Recommendation

Keywords

Schrodinger Inc., SDGR, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSUs, Stock Options, Director Compensation, Executive Compensation, Beneficial Ownership